OHIO SOCIETY OF HEALTH-SYSTEM PHARMACISTS

73^RD ANNUAL MEETING

"ADVANCING PRACTICE THROUGH INNOVATIONS AND OUTCOMES”

MAY 3 & 4, 2012

CROWNE PLAZA COLUMBUS NORTH

Online Registration is now closed - You can register onsite.

Pharmacists, students, and technicians will not want to miss this meeting.This event will provide you with two days of quality continuing education programming!

• Separate breakouts for students and technicians
• Exhibits
• Annual session of the OSHP House of Delegates
• Presentation of this year’s awards for excellence in practice
• And the opportunity to network with your colleagues and meet old and new friends in fun and friendly surroundings

Program at a Glance

Location/Hotel Accommodations:

The OSHP 73rd Annual Meeting will be held at the Crowne Plaza Columbus North, and lodging is available. Reservations can be made by contacting the hotel directly at 614 885-1885. Please identify the "OSHP Room Block” to receive the special $100.00 per night rate plus tax. After April 20, the hotel will make reservations at its regular rate on a space available basis.

The Crowne Plaza Columbus North is located in Columbus off I-71 at Exit 117, State Route 161. Turn west onto Route 161. Turn right on Busch Boulevard. Go three traffic lights to Kingsmill Parkway and turn right. Kingsmill goes directly into the hotel parking lot.

Crowne Plaza Columbus North

6500 Doubletree Avenue, Columbus, OH 43229

Phone: 614 885-1885Fax: 614 885-7222Toll Free:800 228-3429

Thursday Evening Awards Presentation Banquet:

Following a Thursday evening reception sponsored in part by the Council of Ohio Colleges of Pharmacy, come join us at a banquet to honor this year’s recipients of OSHP’s various awards for excellence.

Dress Right:

Business casual dress will be appropriate for all daytime portions of the 73^rd Annual Meeting.Having a light jacket or sweater available is recommended because meeting room temperatures and personal comfort can vary. Evening/business attire will be appropriate for the Thursday evening awards presentation banquet.

Continuing Education Credit:

- Pharmacists

Ohio Northern University is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.All programs are knowledge-based, suitable for pharmacists and/or technicians as noted by objectives.To receive up to 9.5 contact hours (0.95 CEU) ACPE continuing education credit, participants must register, attend session, and complete evaluation. Please allow 4-6 weeks for statements of credit to be issued.The Ohio State Board of Pharmacy approves OSHP as a provider of continuing education. OSHP will provide approved continuing education credits for 1 contact hour (0.1 CEU) of Board approved Ohio Jurisprudence. OSHP continuing education certificates will be available onsite.

- Pharmacy Technicians

This program offers up to 5 continuing education credit hours to pharmacy technicians. Continuing education certificates will be mailed following the program.

Just for Students

Students will not want to miss Friday’s special programming, starting with "ASHP/SPPM Student Leadership Development Workshop”, and continuing with "Getting the most out of IPPE/APPE learning experiences – Who Is in Charge?” NEW THIS YEAR: Thursday evening’s reception will feature a poster session for students! Contact your SSHP president or faculty advisor for details on submitting.

If you do not wish to register on-line, you may download the 73rd Annual Meeting registration brochure and mail or fax in registration with your payment.

Need More Information?

For more information on this year’s programming, contact Educational Affairs Director Jonathan Williams at williaj19@ccf.orgor Executive Vice President Bob Parsons at 740 373-4949 or bobparsons@aol.com

Continuing Education Details

Thursday May 3rd, 2012
8:35am – 9:45am
"Pharmacist Role in Patient-Centered Medical Home"
Michelle Cudnik, PharmD
1 hour – UAN:0048-0000-12-014-L04-P/T
1. List 2011 Patient-Centered medical home standards.
2. Demonstrate ways to integrate pharmacy into these standards.
3. Discuss the implications of the surgeon general report to pharmacy services.
4. Define the accountable care organization model and the role of a pharmacist in it.

9:45am – 10:45am
"Personalized Medicine 101: Pharmacogenetics as a method for Improving Patient Outcomes"
Jon Sprague, RPh, PhD
1 hour – UAN:0048-0000-12-015-L04-P (No technician CE available)
1. Recognize the influence of genetic polymorphisms on the efficacy and affinity of drugs.
2. Compare and contrast pharmacogenetics and pharmacogenomics.
3. Identify basic DNA terminology and genomic variations.
4. Explain how specific polymorphisms would affect the design of a patient's drug dosing regimen.
5. Differentiate between receptors, enzymes and transporters as drug targets and how genetics polymorphisms of these drug targets can influence drug targets can influence drug selection.
6. Propose alterations to a patient's dosing regimen based on pharmacogenetics influence on pharmacodynamics parameters.

11:00am – 12:00pm
"Chronic Obstructive Pulmonary Disease: Current Strategies for Preventing Exacerbations and Improving Patient Outcomes"
Dennis M. Williams, PharmD, BCPS
1 hour – UAN:204-000-12-400-L01P (No technician CE available)
1. Outline the incidence, mortality, and morbidity of COPD in the United States.
2. Explain current evidence-based strategies for the management of COPD, including strategies to minimize exacerbation rates.
3. Discuss emerging treatment options for the management of COPD.
4. Describe the role of the pharmacist in managing patients with COPD.

Technician Track: "Expanding the Role: A Pharmacy Technician's Role in the Pharmacy Practice Model Initiative "
Erin Ortiz Blanco, BSB, CPhT
1 hour – UAN:0048-0000-12-016-L04-T (No pharmacist CE available)
1. Describe the traditional role of pharmacy technicians.
2. Explain PPMI recommendations related to techs.
3. Identify deficiencies in existing practice models.
4. Identify opportunities for formal training & education.
5. Review certification & licensure requirements.
6. Hypothesize about future technician practice.

2:00pm – 3:00pm
Clinical Track – Pediatric Pharmacy Focus
1 hour total – UAN:0048-0000-12-017-L04-P (No technician CE available)
Facilitator – Kim Novak, PharmD, BCPS

"Preventing Perinatal Transmission of HIV"
Amy Dill, PharmD, BCPS
1. Identify appropriate populations for HIV testing.
2. List proper HIV treatment for mom and baby before, during and after delivery.
"Diapers to Depends – Lifelong Care of Patients with Congenital Heart Disease"
Julie Miller, PharmD
1. Describe the increasing prevalence of adults with congenital heart disease.
2. Explain common complications that can result from lifelong CHD.
3. Discuss maternal and fetal complications in patients with CHD.
4. Identify available resources for CHD.

Administrative Track - Drug Shortages
1 hour total – UAN:0048-0000-12-018-L04-P/T

"Surviving the Shortage: A Collaborative Approach to Managing Drug Shortages"
Kelly Besco, PharmD, FISMP and Lorrie Burns, PharmD – co-presenters
1. Identify the impact of national drug shortages on hospital and health system resources.
2. Discuss various techniques that hospitals and health systems may employ to track and respond to drug shortages.
3. Describe conservation measures that may be utilized during a national shortage of
intravenous electrolyte solutions.

"Drug Shortages"
Jay Mirtallo, MS, RPh
1. Discuss drug shortages and the reasons (causes) for their occurrences.
2. Describe the impact of product shortages on the quality and safety of parenteral nutrition (PN) therapy.

3:00pm – 4:30pm
Clinical Track – Oral Chemotherapy
1.5 hours total – UAN:0048-0000-12-019-L01-P (No technician CE available)

"Oral Chemo Challenges: Safety, Adherence, Access and Cost"
Niesha Griffith, MS, RPh, FASHP
1. Define challenges and advantages associated with the use of oral chemotherapy.
2. Describe the importance of ensuring safety checks for oral agents are as rigorous as those for IV chemotherapy.
3. Discuss opportunities for pharmacist involvement in improving patient access and adherence to oral chemotherapy.
4. Describe efforts at the state and national level to address the oral chemotherapy coverage disparity.
"Oral Chemotherapy: New Drug Updates"
Sherry Vogt, PharmD, BCOP
1. Explain the role of new oral chemotherapy agents (OCAs).
2. Describe the mechanism of action (MOA) and potential drug interactions associated with newer OCAs.
3. Discuss possible adverse events that may be associated with newer OCAs and appropriate management strategies.

Administrative Track – "Preceptor Development"
Matt Kauflin, PharmD, BCPS
1 hour (3:15pm – 4:15pm) – UAN:0048-0000-12-020-L04-P (No technician CE available)
1. Define preceptor development.
2. Identify useful resources for preceptor development.
3. Discuss the pros and cons of preceptor development.
4. Identify key characteristics of successful preceptors.

Friday May 4th, 2012
8:30am – 9:30am
New Clinical Pearls
1 hour total – UAN:0048-0000-12-021-L01-P (No technician CE available)
Facilitator – Michael Ganio, PharmD

"Effects of New Oral Anticoagulants on Measures of Anticoagulation"
Doug Anderson., PharmD, DPh, CACP
1. Describe the mechanisms of action of the new anticoagulants and their effects on the clotting cascade.
2. Discuss the parts of the clotting cascade that are measured in standard laboratory tests used to assess anticoagulation.
3. Interpret effects of the new anticoagulants on laboratory test and used to assess anticoagulation.
"Ezogabine and clobazam"
Justin Wesley Cole, PharmD, BCPS
1. Identify the clinical utility of clobazam and ezogabine in the treatment of epilepsy.
"Ivacaftor: The First CFTR Potentiator"
Kim Novak, PharmD, BCPS
1. Review the therapeutic applications of ivacaftor in cystic fibrosis patients with the G551D CFTR gene mutation.
2. Identify key drug interactions with ivacaftor therapy.
3. Recommend appropriate monitoring parameters for ivacaftor therapy.
4. List key medication education points for patients on ivacaftor.
5. Formulate reasonable cost-effective inventory-control strategies for obtaining ivacaftor for patients.
"Bocepravir and telapravir"
Katie McKinney, PharmD, MS, BCPS
1. Review novel therapies for hepatitis C indications, approved in 2011.
2. Discuss the place in therapy for boceprevir and telaprevir.
"The Hedgehog Pathway: New Look at Cancer Treatment"
Karen Kier, R.Ph., Ph.D., M.Sc. BCPS, BCACP
1. Identify the mechanism of action of drugs affecting the hedgehog pathway.
2. Identify the importance of hedgehog pathway in managing patients with cancer.
3. List common adverse events with drugs that work by the hedgehog pathway.
4. List the drugs and common doses of the drugs that work by the hedgehog pathway.

9:45am – 10:45am
"Pharmacy 911"
Nicole Harger, PharmD, BCPS and Veronica Moore, PharmD, BCPS – co-presenters
1 hour – UAN:0048-0000-12-022-L04-P/T
1. Describe current literature identifying pharmacy involvement in the Emergency Department.
2. Compare and contrast the emergency medicine pharmacist's role in a community versus an urban academic medical center.
3. Illustrate strategies for justification of pharmacy services in the Emergency Department.

12:30pm – 1:30pm
"Pain Management: Rational Application of Equianalgesic Ratios to Clinical Care"
Amber Hartman, PharmD
1 hour – UAN:0048-0000-12-023-L04-P (No technician CE available)
1. Describe equianalgesic conversions.
2. Discuss controversies in equianalgesic opioid ratios.
3. Apply rational patient assessment strategies prior to recommending opioid doses.
4. Given a series of patient cases, determine the most appropriate opioid dose.

Student Track: "Getting the most out of IPPE/APPE learning experiences – Who is in Charge?"
Dorcas Letting-Mangira, PharmD
1 hour – UAN:0048-0000-12-024-L04-P (No technician CE available)
1. Identify learning opportunities at the assigned site.
2. Describe strategies to maximize learning at the assigned site.
3. Explain how to provide and receive feedback during your rotation.

1:30pm – 2:30pm
"Therapeutic Hypothermia: A Pharmacist's Guide to Being Cool"
Jodi Dreiling, PharmD, BCPS
1 hour – UAN:0048-0000-12-025-L04-P (No technician CE available)
1. Evaluate the evidence supporting therapeutic hypothermia.
2. Identify the appropriate patient for therapeutic hypothermia.
3. Discuss how to manage a patient during therapeutic hypothermia.

2:45pm – 3:45Pm
"Ohio Jurisprudence -- Laws and Rules”
Paul Kover R.Ph.
1 hour – Ohio State Board of Pharmacy Program Number 036-152-12-001-P/T. 0.1 CEU
1. Review key points regarding state and federal legislation affecting pharmacy practice.
2. Review key point regarding state regulatory developments affecting pharmacy practice.

Online Registration is now closed - You can register onsite.